Free Trial

Oberweis Asset Management Inc. Acquires New Position in Blend Labs, Inc. (NYSE:BLND)

Blend Labs logo with Computer and Technology background

Oberweis Asset Management Inc. acquired a new stake in shares of Blend Labs, Inc. (NYSE:BLND - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 964,700 shares of the company's stock, valued at approximately $4,061,000. Oberweis Asset Management Inc. owned 0.38% of Blend Labs at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Price T Rowe Associates Inc. MD lifted its holdings in Blend Labs by 23.5% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 94,242 shares of the company's stock worth $397,000 after purchasing an additional 17,914 shares in the last quarter. Hsbc Holdings PLC grew its holdings in shares of Blend Labs by 75.2% in the fourth quarter. Hsbc Holdings PLC now owns 48,414 shares of the company's stock valued at $207,000 after purchasing an additional 20,780 shares in the last quarter. Stifel Financial Corp increased its position in Blend Labs by 96.4% in the fourth quarter. Stifel Financial Corp now owns 20,375 shares of the company's stock worth $86,000 after purchasing an additional 10,000 shares during the last quarter. Mirabella Financial Services LLP purchased a new stake in Blend Labs during the fourth quarter valued at $6,765,000. Finally, MetLife Investment Management LLC lifted its position in Blend Labs by 9.6% during the fourth quarter. MetLife Investment Management LLC now owns 137,579 shares of the company's stock valued at $579,000 after purchasing an additional 12,019 shares during the last quarter. Hedge funds and other institutional investors own 52.56% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on BLND shares. Wells Fargo & Company reduced their target price on shares of Blend Labs from $6.00 to $5.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. Keefe, Bruyette & Woods reduced their price target on Blend Labs from $3.85 to $3.50 and set a "market perform" rating on the stock in a report on Monday, March 3rd. UBS Group decreased their price objective on shares of Blend Labs from $4.00 to $3.50 and set a "neutral" rating for the company in a report on Friday, February 28th. Finally, Canaccord Genuity Group lowered their target price on Blend Labs from $5.75 to $5.25 and set a "buy" rating for the company in a report on Friday, February 28th. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $4.70.

View Our Latest Stock Analysis on BLND

Blend Labs Stock Down 2.1 %

Shares of NYSE BLND traded down $0.07 during mid-day trading on Wednesday, reaching $3.29. 643,917 shares of the company were exchanged, compared to its average volume of 2,946,950. Blend Labs, Inc. has a 1 year low of $2.08 and a 1 year high of $5.53. The firm has a 50-day moving average of $3.34 and a 200 day moving average of $3.89. The stock has a market cap of $854.29 million, a price-to-earnings ratio of -9.68 and a beta of 1.29.

Blend Labs Company Profile

(Free Report)

Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.

Further Reading

Institutional Ownership by Quarter for Blend Labs (NYSE:BLND)

Should You Invest $1,000 in Blend Labs Right Now?

Before you consider Blend Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.

While Blend Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines